STIFEL 2026: REGENXBIO will have its pivotal studies for wet AMD read out before the end of the year - combined, they are the largest study of a gene therapy ever

0:00-8:18

CEO Curran Simpson sets the table for the readouts and describes what he believes they need to show in order to succeed. Plus, updates on the DMD program and RGX-121.

B-

BiotechTV - News

@biotechtvnews

#pivotalstudies #wetamdread #largeststudy #lifesciences

The Nile